KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Total Current Liabilities: 2009-2024

Historic Total Current Liabilities for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to $12.8 billion.

  • Teva Pharmaceutical Industries' Total Current Liabilities fell 16.71% to $11.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 billion, marking a year-over-year decrease of 16.71%. This contributed to the annual value of $12.8 billion for FY2024, which is 4.48% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Total Current Liabilities stood at $12.8 billion for FY2024, which was up 4.48% from $12.2 billion recorded in FY2023.
  • In the past 5 years, Teva Pharmaceutical Industries' Total Current Liabilities ranged from a high of $13.2 billion in FY2020 and a low of $11.0 billion during FY2021.
  • For the 3-year period, Teva Pharmaceutical Industries' Total Current Liabilities averaged around $12.2 billion, with its median value being $12.2 billion (2023).
  • In the last 5 years, Teva Pharmaceutical Industries' Total Current Liabilities declined by 16.23% in 2021 and then increased by 6.78% in 2023.
  • Yearly analysis of 5 years shows Teva Pharmaceutical Industries' Total Current Liabilities stood at $13.2 billion in 2020, then dropped by 16.23% to $11.0 billion in 2021, then increased by 4.01% to $11.5 billion in 2022, then increased by 6.78% to $12.2 billion in 2023, then grew by 4.48% to $12.8 billion in 2024.